Anti-desmoglein 1 antibodies in healthy related and unrelated subjects and patients with pemphigus foliaceus in endemic and non-endemic areas from Tunisia.
BACKGROUND
Pemphigus foliaceus is an autoimmune blistering skin disease characterized by the production of pathogenic IgG autoantibodies directed against desmoglein 1.


OBJECTIVE
To determine the prevalence of anti-desmoglein 1 antibodies in healthy subjects and their distribution in the different regions of Tunisia and to better identify endemic areas of pemphigus foliaceus.


METHODS
We tested, by enzyme-linked immunoserbent assay, sera of 270 normal subjects recruited from different Tunisian areas and 203 related healthy relatives to 90 Tunisian pemphigus foliaceus patients. Results Seventy-six patients (84.4%), 20 healthy controls (7.4%), and 32 relatives (15.76%) had anti-desmoglein 1 antibodies. In southern regions where pemphigus foliaceus is associated with a significant sex ratio imbalance (9 female : 1 male in the south vs. 2.3 : 1 in the north) and a lower mean age of disease onset (33.5 in the south vs. 45 years in the north), a higher prevalence of anti-desmoglein 1 antibodies in healthy controls was observed (9.23% vs. 5.71% in the north). Interestingly, the highest prevalence of anti-desmoglein 1 antibodies in healthy relatives (up to 22%) was observed in the most rural southern localities. More than half anti-desmoglein 1-positive healthy controls were living in rural conditions with farming as occupation, which suggests that this activity may expose the subjects to particular environmental conditions.


CONCLUSIONS
These results show that the endemic features of Tunisian pemphigus foliaceus are focused in these southern areas more than in other areas and that both environmental and genetic factors contribute to the disease.
Abida
O
O
Immunology Department, Habib Bourguiba Hospital, Sfax, Tunisia. olfaabida@yahoo.fr
Kallel-Sellami
M
M
Joly
P
P
Ben Ayed
M
M
Zitouni
M
M
Masmoudi
A
A
Mokni
M
M
Fezzaa
B
B
Ben Osman
A
A
Kammoun
M R
MR
Gilbert
D
D
Turki
H
H
Tron
F
F
Masmoudi
H
H
Makni
S
S
D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D051182:Desmogleins / Q000235:genetics / Q000276:immunology*; D019353:Endemic Diseases; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D010392:Pemphigus / Q000097:blood / Q000453:epidemiology* / Q000276:immunology*; D015995:Prevalence; D014416:Tunisia / Q000453:epidemiology
D000888:Antibodies, Anti-Idiotypic; D015415:Biomarkers; D051182:Desmogleins; D007074:Immunoglobulin G